Approvals/TGA/APO-MONTELUKAST montelukast 5 mg (as sodium) chewable tablet bottle

Approved

STANDARD

APO-MONTELUKAST montelukast 5 mg (as sodium) chewable tablet bottle

Arrotex Pharmaceuticals Pty Ltd🇦🇺 Therapeutic Goods Administration

Approval Id: 71822e2b8373c703
Product Name: APO-MONTELUKAST montelukast 5 mg (as sodium) chewable tablet bottle
Artg Id: 179110
Artg Name: APO-MONTELUKAST montelukast 5 mg (as sodium) chewable tablet bottle
Sponsor: Arrotex Pharmaceuticals Pty Ltd
Company Detail Path: /organization/arrotex-pharmaceuticals-pty-ltd
Artg Date: 2011-11-15
Registration Type: Medicine
Therapeutic Good Type: Medicine
Licence Status: A
Licence Category: RE

Approved

Agency

TGA

Country

🇦🇺

Approval Date

May 30, 2025

Approval ID

71822e2b8373c703

Type

Standard